News
Four new members elected to the Board of Directors of MetrioPharm AG
— Their appointment was initiated by the outgoing board of directors. The four new members will bring many years of experience in the biotech and pharmaceutical industry, especially in research and development, pharmaceutical strategy and regulatory affairs.
MetrioPharm AG, a biotech company developing drugs for inflammatory and infectious diseases, announced today that four new members were elected to the Board of Directors at an Extraordinary General Meeting on April 25, 2025. The new members are Dr. Harald Fricke, Dr. Martina Muttke, Dr. Stephan Rietiker and Dr. Jörg Zwicker. The board members Jörg Gruber and Christoph von Moos will be remaining on the board.